Corey McCann - 15 Feb 2023 Form 4 Insider Report for Pear Therapeutics, Inc.

Role
President and CEO, Director
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Feb 2023
Net transactions value
$0
Form type
4
Filing time
17 Feb 2023, 15:12:24 UTC
Previous filing
24 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Restricted Stock Units Award $0 +2,857,142 $0.000000 2,857,142 15 Feb 2023 Class A Common Stock 2,857,142 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock.
F2 The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026.